the whole quarter and this resulted in higher demand and the company’s Methyl Ester (B100) sales volume from both quarter 3/2016 and quarter 2/2017. However, the increase in crude palm oil inventory
the Memorandum of Association to be in accordance with the reduction in registered capital and to be presented to the shareholders for approval. 3. Approve the increase of registered capital and
Company, therefore, the interesting bearing debt to equity ratio and the debt to equity ratio of shareholders do not exceed 1:1 which is in compliance with the Company’s policy. The financial costs are also
2 new investors on the share capital increase in a proportion of 49 percent on Pace Project One Co., Ltd and 48.7 percent on Pace Project Three Co., Ltd. The Company remeasured the remaining
at June 30, 2018, the consolidated debt to equity ratio was 0.45 time and the consolidated net debt to equity ratio was considerably low at 0.30 time. Financial Highlights 2Q 2018 2Q 2017 Change 6M
2016 Year 2015 increase (decrease) Million Baht % Million Baht % Million Baht % Revenue Revenue from immovable property sales 708.62 89.23% 919.19 98.12% -210.57 -22.91% Other income 85.57 10.77% 17.60
sales expenses (excluding ownership transfer expenses) increase 46.18% as a result of the brokerage fee from the recognized income of 25.62 million THB of Lumpini Suite Petchaburi - Makkasan. Main income
1H/ 2017, accounted for 22.85% increase due to the introduction of 9 new branches compared to the same period last year. The Group had other revenues of THB 5.61 million in 1H/ 2018 which increased
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั